mRNA expression
Gene:
NUF2 (official gene symbol)Other symbol:
CDCA1CT family:
CT106CT identifier:
CT106High-throughput data (expression in cancer samples)
SAGE(short, 10 nt tags) Show
SAGE(long, 17 nt tags) Show
MPSS (short, 13 nt tags) Show
EST Show
Published data of mRNA expression in normal tissues
ShowTissue | Methodology | PMID |
---|---|---|
Stomach | RT-PCR | 19081476 |
Colon | RT-PCR | 19081476 |
Lung | RT-PCR | 19081476 |
Prostate | RT-PCR | 19081476 |
Peripheral blood leukocyte | RT-PCR | 19081476 |
Bladder | RT-PCR | 19081476 |
Testis | Northern blot | 17079454 |
Testis | RT-PCR | 18770861 |
Thymus | RT-PCR | 18770861 |
Published data of mRNA expression in neoplasias
Hematologic malignacies Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Acute myeloid leukemia |
0/16 (0%) | c-DNA microarray | 18770861 | |
Chronic myeloid leukemia |
14/17 (82%) | c-DNA microarray | ||
Lymphoma |
7/9 (78%) | c-DNA microarray | ||
Myeloma |
Newly diagnosed patient | 187/320 (58%) | Microarray | 21791470 |
Myeloma |
Relapse patient | 148/264 (56%) | Microarray |
Bladder cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Bladder carcinoma |
28/28 (100%) | c-DNA microarray | 18770861 |
Breast cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Breast carcinoma |
25/39 (64%) | c-DNA microarray | 18770861 |
Colon & Rectum cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Colon cancer |
4/10 (40%) | c-DNA microarray | 18770861 |
Esophageal cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Esophageal carcinoma |
4/18 (22%) | c-DNA microarray | 18770861 |
Gastric cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Gastrict carcinoma |
10/10 (100%) | RT-PCR | 19081476 | |
Gastrict carcinoma |
0/5 (0%) | c-DNA microarray | 18770861 |
Gynecological cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Cervical cancer |
12/16 (75%) | c-DNA microarray | 18770861 |
Hepatobiliary cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Cholangiocellular cancer |
12/12 (100%) | c-DNA microarray | 18770861 |
Kidney cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Renal cell carcinoma |
7/7 (100%) | c-DNA microarray | 18770861 |
Lung cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Adenocarcinoma |
4/8 (50%) | qRT-PCR | 17079454 | |
Squamous cell carcinoma |
6/8 (75%) | qRT-PCR | ||
Non small cell lung carcinoma |
18/19 (95%) | RT-PCR | 18770861 | |
Non small cell lung carcinoma |
9/9 (100%) | c-DNA microarray | ||
Small cell lung carcinoma |
15/15 (100%) | c-DNA microarray |
Prostate cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Prostate carcinoma |
17/20 (85%) | c-DNA microarray | 18770861 |
Sarcoma Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Osteosarcoma |
14/19 (74%) | c-DNA microarray | 18770861 | |
Sarcoma |
18/36 (50%) | c-DNA microarray |
Published data of mRNA expression in Cell Lines
ShowOrigin tissue | Cell Line ID | Frequency | Methodology | PMID |
---|---|---|---|---|
Bladder carcinoma | EJ-1 T24 |
2/2 | RT-PCR | 19081476 |
Breast carcinoma | CRL1500 MCF7 |
RT-PCR | 18770861 | |
Breast carcinoma | MDA-MB-453 MDA-MB-231 MCF7 |
3/3 (100%) | RT-PCR | 19081476 |
Bronchioloalveolar cell carcinomas | NCI-H1666 NCI-H1781 |
2/2 (100%) | qRT-PCR | 17079454 |
Cervical carcinoma | ME-180 Hela |
2/2 (100%) | RT-PCR | 19081476 |
Colon carcinoma | COLO320 DLD-1 KM12C MIP101 |
4/4 (100%) | RT-PCR | 19081476 |
Colon carcinoma | sw620 | RT-PCR | 18770861 | |
Esophageal carcinoma | TE10 | RT-PCR | 18770861 | |
Gastrict carcinoma | MKN7 IM95 IM95m MKN74 MKN45 NUGC-3 Kato III OCUM-1 ECC10 |
8/8 (100%) | RT-PCR | 19081476 |
Human coronary arterial endothelial cells | HCAEC | qRT-PCR | 17082211 | |
Large cell lung carcinoma | LX1 SCLCDMS114 DMS273 SBC-3 SBC-5 |
5/5 (100%) | qRT-PCR | 17079454 |
Lung adenocarcinoma | A427 A549 LC319 PC3 PC9 PC14 NCI-H1373 |
7/7 (100%) | qRT-PCR | 17079454 |
Lung adenocarcinoma | 1-87 A549 PC14 RERF-LC-KO |
RT-PCR | 18770861 | |
Lung carcinoma | A549 LU65 Lu99B PC9 |
4/4 (100%) | RT-PCR | 19081476 |
Lung carcinoma- SCLC | SBC5 LU65 |
RT-PCR | 18770861 | |
Lymphoma | Daudi U937 A4/Fuk A3/KAW |
4/4 (100%) | RT-PCR | 19081476 |
Melanoma | 164 | RT-PCR | 18770861 | |
Melanoma | G361 | 1/1 (100%) | RT-PCR | 19081476 |
Oral carcinoma | Co9-22 | RT-PCR | 18770861 | |
Pancreatic carcinoma | PANC-1 | RT-PCR | 18770861 | |
Pancreatic carcinoma | PK-45 AsPC-1 PANC-1 PK-59 MIAPaca2 |
4/4 (100%) | RT-PCR | 19081476 |
Prostate carcinoma | DU145 PC3 LNCaP-FGC |
3/3 (100%) | RT-PCR | 19081476 |
Squamous cell lung carcinoma | EBC-1 LC-1sq |
RT-PCR | 18770861 | |
Squamous cell lung carcinoma | RERF-LCAI SK-MES-1 EBC-1 LU61 NCI-H226 NCI-H520 NCI-H647 NCI-H1703 NCI-H2170 |
9/9 (100%) | qRT-PCR | 17079454 |
2005-2009© CT Antigens Database